Author: Cillóniz, C.; San José, A.; Torres, A.
Title: Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia Cord-id: welsrjao Document date: 2016_1_1
ID: welsrjao
Snippet: Mortality in community acquired pneumonia (CAP) has not decreased in the intensive care unit (ICU), despite progress in antimicrobial therapy [1, 2]. Approximately 10% of patients hospitalized with CAP are admitted to the ICU [3]. In a multicenter study by Mongardon et al. in patients with severe pneumococcal CAP admitted to the ICU, the mortality rate was 29%, with high proportions of patients in septic shock and needing mechanical ventilation [4]. Severe CAP is a progressive disease and patien
Document: Mortality in community acquired pneumonia (CAP) has not decreased in the intensive care unit (ICU), despite progress in antimicrobial therapy [1, 2]. Approximately 10% of patients hospitalized with CAP are admitted to the ICU [3]. In a multicenter study by Mongardon et al. in patients with severe pneumococcal CAP admitted to the ICU, the mortality rate was 29%, with high proportions of patients in septic shock and needing mechanical ventilation [4]. Severe CAP is a progressive disease and patients may die despite early and adequate antibiotic treatment. The host local and systemic inflammatory immune response in patients with severe CAP is exacerbated and disproportionate and this is probably the main cause for the high mortality in this specific population, as it contributes to impaired alveolar gas exchange, sepsis and end-organ dysfunction [5]. In this specific population of patients with severe CAP, adjuvant treatments, such as corticosteroids, may be beneficial.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and adjunctive treatment: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low severity: 1, 2, 3
- acute ards respiratory distress syndrome and lung bacterial burden: 1
Co phrase search for related documents, hyperlinks ordered by date